Comparative immunogenicity of 146S, 75S and 12S particles of foot-and-mouth disease virus

scientific article published in January 1982

Comparative immunogenicity of 146S, 75S and 12S particles of foot-and-mouth disease virus is …
instance of (P31):
scholarly articleQ13442814

External links are
P6179Dimensions Publication ID1001421005
P356DOI10.1007/BF01314726
P698PubMed publication ID6293410

P2093author name stringW K Chong
T R Doel
P2860cites workAntibody response to viral antigens.Q39938393
Radial immuno-diffusion and serum-neutralisation techniques for the assay of antibodies to swine vesicular diseaseQ39987220
Biochemical Mapping of the Foot-and-Mouth Disease Virus GenomeQ40079325
Stability and immunogenicity of empty particles of foot-and-mouth disease virusQ40214915
Morphogenesis of foot-and-mouth disease virus. I. Role of procapsids as virion PrecursorsQ40254358
A Comparative Chemical and Serological Study of the Full and Empty Particles of Foot-and Mouth Disease VirusQ40312952
A 65 S PARTICLE CONTAINING VIRAL PROTEIN IN CELLS INFECTED WITH FOOT-AND-MOUTH DISEASE VIRUS.Q45712931
Qualitative assessment of 146 S particles of foot-and-mouth disease virus in preparations destined for vaccinesQ45800162
Thermal stability of foot-and-mouth disease virusQ45800767
Chemical and physical properties of foot-and-mouth disease virus: a comparison with Maus Elberfeld virusQ45820402
A study of the physical properties of the immunizing antigen of foot-and-mouth disease virus and the effect of various inactivating agents on its structureQ45823495
Further evidence for multiple proteins in the foot-and-mouth disease virus particleQ45827343
P433issue2
P921main subjectfoot-and-mouth disease virusQ1911079
foot-and-mouth diseaseQ152401
P1104number of pages7
P304page(s)185-191
P577publication date1982-01-01
P1433published inArchives of VirologyQ2860564
P1476titleComparative immunogenicity of 146S, 75S and 12S particles of foot-and-mouth disease virus
P478volume73

Reverse relations

cites work (P2860)
Q39578733Antibody response in mice inoculated with DNA expressing foot-and-mouth disease virus capsid proteins
Q40111517Antigenic variation in foot-and-mouth disease: studies based on the virus neutralization reaction
Q89712313Biocompatible cationic solid lipid nanoparticles as adjuvants effectively improve humoral and T cell immune response of foot and mouth disease vaccines
Q102142372Characterization and stabilization in process development and product formulation for super large proteinaceous particles
Q33537528Characterization of foot-and-mouth disease virus antigen by surface-enhanced laser desorption ionization-time of flight-mass spectrometry in aqueous and oil-emulsion formulations
Q44643781Chitosan-based systems for intranasal immunization against foot-and-mouth disease.
Q40461832Comparative studies of the capsid precursor polypeptide P1 and the capsid protein VP1 cDNA vectors for DNA vaccination against foot-and-mouth disease virus.
Q40592868DNA vaccine (P1-2A-3C-pCDNA) co-administered with Bovine IL-18 gives protective immune response against Foot and Mouth Disease in cattle.
Q91621211Development of GEM-PA-nanotrap for purification of foot-and-mouth disease virus
Q42282512Development of a liquid-phase blocking ELISA based on foot-and-mouth disease virus empty capsid antigen for seromonitoring vaccinated animals
Q40015542Dissecting the roles of VP0 cleavage and RNA packaging in picornavirus capsid stabilization: the structure of empty capsids of foot-and-mouth disease virus
Q83400965Effect of thiomersal on dissociation of intact (146S) foot-and-mouth disease virions into 12S particles as assessed by novel ELISAs specific for either 146S or 12S particles
Q92408035Engineering viable foot-and-mouth disease viruses with increased acid stability facilitate the development of improved vaccines
Q47590462Enhanced protection against FMDV in cattle after prime- boost vaccination based on mucosal and inactivated FMD vaccine
Q90163207Evaluation of Quality Control Methods for Foot-And-Mouth Disease Vaccines by High-Performance Liquid Chromatography
Q35044859FMD vaccines
Q45399254Foliar extracts from transgenic tomato plants expressing the structural polyprotein, P1-2A, and protease, 3C, from foot-and-mouth disease virus elicit a protective response in guinea pigs
Q45365896Foot and mouth disease (FMD) virus: quantification of whole virus particles during the vaccine manufacturing process by size exclusion chromatography
Q42177158Foot-and-mouth disease vaccination induces cross-reactive IFN-γ responses in cattle that are dependent on the integrity of the 140S particles
Q42253346Heterogeneity in the Antibody Response to Foot-and-Mouth Disease Primo-vaccinated Calves
Q40433851Immune response in guinea pigs vaccinated with DNA vaccine of foot-and-mouth disease virus O/China99.
Q45738400Immune responses and protection against foot-and-mouth disease virus (FMDV) challenge in swine vaccinated with adenovirus-FMDV constructs
Q91941540Immunogenicity and protective efficacy of a novel foot-and-mouth disease virus empty-capsid-like particle with improved acid stability
Q34661842Induction of mucosal immune responses and protection of cattle against direct-contact challenge by intranasal delivery with foot-and-mouth disease virus antigen mediated by nanoparticles
Q91935369Inherent biophysical stability of foot-and-mouth disease SAT1, SAT2 and SAT3 viruses
Q40061913Isolation of Single-Domain Antibody Fragments That Preferentially Detect Intact (146S) Particles of Foot-and-Mouth Disease Virus for Use in Vaccine Quality Control.
Q54377073Microvascular endothelial cells play potential immunoregulatory roles in the immune response to foot-and-mouth disease vaccines.
Q89518630Negatively charged amino acids at the foot-and-mouth disease virus capsid reduce the virion-destabilizing effect of viral RNA at acidic pH
Q40664785Novel 6xHis tagged foot-and-mouth disease virus vaccine bound to nanolipoprotein adjuvant via metal ions provides antigenic distinction and effective protective immunity
Q45394711Production of monoclonal antibodies against whole virus particles of foot-and-mouth disease virus serotype O and A and their potential use in quantification of intact virus for vaccine manufacture
Q44397703Protective immune response of the capsid precursor polypeptide (P1) of foot and mouth disease virus type 'O' produced in Pichia pastoris
Q35941324Quantitative Detection of the Foot-And-Mouth Disease Virus Serotype O 146S Antigen for Vaccine Production Using a Double-Antibody Sandwich ELISA and Nonlinear Standard Curves
Q38744534SAT2 Foot-and-Mouth Disease Virus Structurally Modified for Increased Thermostability
Q39079735Selection and characterization of an acid-resistant mutant of serotype O foot-and-mouth disease virus
Q39002258Single amino acid substitution of VP1 N17D or VP2 H145Y confers acid-resistant phenotype of type Asia1 foot-and-mouth disease virus
Q40273752Stabilization study of inactivated foot and mouth disease virus vaccine by size-exclusion HPLC and differential scanning calorimetry
Q42150623Stabilizing effects of excipients on dissociation of intact (146S) foot-and-mouth disease virions into 12S particles during storage as oil-emulsion vaccine
Q27702186Structure-based energetics of protein interfaces guides foot-and-mouth disease virus vaccine design
Q39891157Synthesis of empty capsid-like particles of Asia I foot-and-mouth disease virus in insect cells and their immunogenicity in guinea pigs
Q71275857The evaluation of a physical method for the quantification of inactivated poliovirus particles and its relationship to D-antigenicity and potency testing in rats
Q45324143The pH stability of foot-and-mouth disease virus
Q94539244The role of viral particle integrity in the serological assessment of foot-and-mouth disease virus vaccine-induced immunity in swine
Q92340066Thermostability of the Foot-and-Mouth Disease Virus Capsid Is Modulated by Lethal and Viability-Restoring Compensatory Amino Acid Substitutions
Q37403499Vaccination against foot-and-mouth disease virus: strategies and effectiveness
Q92230485Validation of a high performance liquid chromatography method for quantitation of foot-and-mouth disease virus antigen in vaccines and vaccine manufacturing
Q39868443Viral RNA modulates the acid sensitivity of foot-and-mouth disease virus capsids.

Search more.